Approvals in 2017: gene therapies and site-agnostic indications. - PubMed - NCBI

Approvals in 2017: gene therapies and site-agnostic indications. - PubMed - NCBI

Nat Rev Clin Oncol. 2018 Mar;15(3):127-128. doi: 10.1038/nrclinonc.2018.11. Epub 2018 Jan 31.

Approvals in 2017: gene therapies and site-agnostic indications.

Blumenthal GM1, Pazdur R1.

Author information

PMID:

 

29384145

 

DOI:

 

10.1038/nrclinonc.2018.11